Two reports of euDKA in the United Kingdom pertained to patients with pancreatic insufficiency taking dapagliflozin.5 Although initially presumed to have T2DM, these patients had secondary diabetes in the context of chronic pancreatitis and distal pancreatectomy, respectively, with low levels of insulin and C-peptide and negative autoantibodies. Here, INS is linked to type 2 diabetes mellitus.